Literature DB >> 30532881

A case of Brugada syndrome coexisting with vasospastic angina: Caution should be taken when using calcium channel blockers.

Takahisa Yoshikawa1, Chisato Izumi1, Kazuaki Kaitani1, Yoshihisa Nakagawa1.   

Abstract

Although calcium channel blockers have been reported to aggravate Brugada-type electrocardiogram (ECG) abnormalities, there have been few reports in clinical settings. We present a case of Brugada syndrome coexisting with vasospastic angina, in whom Brugada-type ST-segment elevation was aggravated and ventricular fibrillation attacks occurred by calcium channel blocker treatment. When prescribing calcium channel blockers to patients with Brugada syndrome, it is important to pay careful attention to changes in their ECG pattern.

Entities:  

Keywords:  Brugada syndrome; Calcium channel blockers; Diltiazem; Vasospastic angina; Ventricular fibrillation

Year:  2011        PMID: 30532881      PMCID: PMC6265419          DOI: 10.1016/j.jccase.2011.09.001

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT/VF. Anesthesia unmasked Brugada syndrome.

Authors:  Kevin Vernooy; Serge Sicouri; Robert Dumaine; Kui Hong; Antonio Oliva; Elena Burashnikov; Carl Timmermans; Tammo Delhaas; Harry J G M Crijns; Charles Antzelevitch; Luz-Maria Rodriguez; Ramon Brugada
Journal:  Heart Rhythm       Date:  2006-07-07       Impact factor: 6.343

2.  Shortening of the ventricular fibrillatory intervals after administration of verapamil in a patient with Brugada syndrome and vasospastic angina.

Authors:  Masaomi Chinushi; Minoru Tagawa; Yuichi Nakamura; Yoshifusa Aizawa
Journal:  J Electrocardiol       Date:  2006-02-28       Impact factor: 1.438

3.  Genotype-phenotype correlation in tissue models of Brugada syndrome simulating patients with sodium and calcium channelopathies.

Authors:  Hiroshi Morita; Douglas P Zipes; Shiho T Morita; Jiashin Wu
Journal:  Heart Rhythm       Date:  2010-02-01       Impact factor: 6.343

4.  Role of sodium and calcium channel block in unmasking the Brugada syndrome.

Authors:  Jeffrey M Fish; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2004-07       Impact factor: 6.343

5.  Similarities between Brugada syndrome and ischemia-induced ST-segment elevation. Clinical correlation and synergy.

Authors:  Masaomi Chinushi; Hiroshi Furushima; Yasutaka Tanabe; Takashi Washizuka; Yoshifusa Aizawaz
Journal:  J Electrocardiol       Date:  2005-10       Impact factor: 1.438

6.  Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.

Authors:  G X Yan; C Antzelevitch
Journal:  Circulation       Date:  1999-10-12       Impact factor: 29.690

7.  Multiple episodes of ventricular tachycardia induced by silent coronary vasospasm.

Authors:  Ali Alizadeh Sovari; David Cesario; Abraham G Kocheril; Ramon Brugada
Journal:  J Interv Card Electrophysiol       Date:  2008-02-23       Impact factor: 1.900

8.  Effects of verapamil on anterior ST segment and ventricular fibrillation cycle length in patients with Brugada syndrome.

Authors:  Masaomi Chinushi; Kenichi Iijima; Minoru Tagawa; Satoru Komura; Hiroshi Furushima; Yoshifusa Aizawa
Journal:  J Electrocardiol       Date:  2009-04-07       Impact factor: 1.438

9.  ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or ergonovine maleate in patients with Brugada syndrome.

Authors:  Takashi Noda; Wataru Shimizu; Atsushi Taguchi; Kazuhiro Satomi; Kazuhiro Suyama; Takashi Kurita; Naohiko Aihara; Shiro Kamakura
Journal:  J Am Coll Cardiol       Date:  2002-11-20       Impact factor: 24.094

10.  Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome.

Authors:  T Miyazaki; H Mitamura; S Miyoshi; K Soejima; Y Aizawa; S Ogawa
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

  10 in total
  1 in total

1.  Bepridil monotherapy failed to prevent coronary vasospasm in a Brugada syndrome patient.

Authors:  Takuro Kazatani; Akinori Higaki; Yuta Tanaka; Yoshitaka Kawada; Go Hiasa; Tadakatsu Yamada; Hideki Okayama
Journal:  Oxf Med Case Reports       Date:  2022-08-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.